Status:
COMPLETED
Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Brain Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This goal of this research study is to learn more about fatigue, sleep quality, and other symptoms in patients with primary brain tumors who are being treated with radiation therapy. Objectives: PRI...
Detailed Description
Questionnaires: If you decide to take part in this study, before starting radiation therapy, weekly during radiation therapy, and again 3-4 weeks and 6-8 weeks after completing radiation therapy, you...
Eligibility Criteria
Inclusion
- A new diagnosis of a primary glioma, astrocytoma, oligodendroglioma, oligo-astrocytoma, ependymoma, tanycytic ependymoma, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligo-astrocytoma, anaplastic ependymoma
- Radiation therapy as part of the plan of care
- Age \>/= 18 years of age. Children are excluded from this study because of differences in tumor location and biology with differing symptom clusters. A separate study will be conducted in the future with children.
- Ability to speak, write, and read English
- On corticosteroids at the initiation of radiation therapy.
Exclusion
- Tumors involving the suprasellar region, including the pituitary and hypothalamus
- Cognitive deficits which limit ability to self-report symptoms.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00876499
Start Date
January 1 2009
End Date
December 1 2013
Last Update
January 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030